Overview

Isolated Thoracic Perfusion (ITP-F) for MPM

Status:
Completed

Trial end date:
2015-05-01

Target enrollment:

Participant gender:

Summary

This is an observational study of isolated thoracic perfusion with subsequent hemofiltration to lower the concentration of the cytotoxic drugs as a locoregional therapeutic strategy in malignant pleural mesothelioma.

Details

Lead Sponsor:

Medias Klinikum for Surgical Oncology

Treatments:

Mitoxantrone